Menu

Stem Cells: Opportunities, Hurdles, and Promises

The Scientist is bringing together a panel of experts to discuss the grand opportunity stem cells represent.

Jul 30, 2018
The Scientist Creative Services Team

Stem Cells: Opportunities, Hurdles, and Promises from thescientistllc on Vimeo.

Since Sir. Martin Evans’ 1981 identification of embryonic stem cells in mice, stem cells have been at the center of the drive to revolutionize medicine and the drug discovery process. In 1998, human embryonic stem cells were grown in a lab, and the field was further boosted in 2006 with the pivotal discovery of induced pluripotent stem (iPS) cell techniques, which removed the need to destroy embryos. But stem cell research has not come without hurdles and controversy. How far has research come since the first groundbreaking reports were published? For further insight into ongoing challenges in the stem cell arena, the mechanisms and roadblocks encountered in iPS cell technology, and the grand opportunity stem cells represent, The Scientist is bringing together a panel of experts who will share their research, explore cellular reprogramming, and discuss the next steps.

Topics to be covered:

  • Molecular mechanism of induced pluripotency
  • Roadblocks to iPSC reprogramming, and erasing transcriptional memory in cellular reprogramming

Meet the Speaker:

Matthias Stadtfeld, PhD
Assistant Professor
Skirball Institute of Biomolecular Medicine
New York University School of Medicine


Kejin Hu, PhD, MPH
Assistant Professor
UAB Stem Cell Institute
Department of Biochemistry and Molecular Genetics
University of Alabama at Birmingham

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.